Acura Pharmaceuticals, Inc.
ACUROTCHealthcare● Active
$0.00
+$0.00(+150.00%)
Market Cap$33001
P/E Ratio—
52W High$0.01
52W Low$0.0001
Acura Pharmaceuticals, Inc. (ACUR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ACUR · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.56M | $3.57M | $2.66M | $0.41M | $2.97M |
| Cost of Revenue | $0.09M | $1.78M | $0.00M | $0.00M | $0.13M |
| Gross Profit | $1.47M | $3.57M | $2.65M | $0.41M | $2.84M |
| Gross Margin %(computed) | 94.24% | 99.94% | 99.92% | 99.57% | 95.68% |
| Operating Expenses | |||||
| R&D Expenses | $1.52M | $1.78M | $1.50M | $1.76M | $3.72M |
| G&A Expenses | $1.25M | $2.55M | $1.88M | $2.57M | $0.00M |
| Total Operating Expenses | $1.25M | $4.33M | $3.38M | $4.33M | $8.06M |
| Operating Income | ($1.21M) | ($0.76M) | ($0.72M) | ($3.92M) | ($5.22M) |
| Operating Margin %(computed) | -77.67% | -21.23% | -27.29% | -954.88% | -176.16% |
| Interest Income | $0.00M | $0.00M | $0.01M | $0.17M | $0.00M |
| Interest Expense | $0.20M | $0.45M | $0.46M | $0.40M | $0.60M |
| Income Before Tax | ($0.88M) | ($1.21M) | ($3.77M) | ($3.84M) | ($5.82M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | ($0.14M) |
| Net Income | ($0.88M) | ($1.21M) | ($3.77M) | ($3.84M) | ($5.68M) |
| Net Margin %(computed) | -56.24% | -33.84% | -142.04% | -937.07% | -191.57% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.04 | $-0.14 | $-0.18 | $-0.36 |
| Wtd Avg Shares | 43.95M | 30.20M | 26.72M | 21.15M | 15.90M |
| EBITDA | ($0.59M) | ($0.63M) | ($3.04M) | ($3.17M) | ($4.93M) |
| EBITDA Margin %(computed) | -37.68% | -17.73% | -114.38% | -772.44% | -166.12% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Acura Pharmaceuticals, Inc. data
About Acura Pharmaceuticals, Inc. (ACUR) Income Statement
Acura Pharmaceuticals, Inc. (ACUR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, ACUR reported revenue of $0.00B, gross profit of $0.00B (gross margin 94.24%), and net income of ($0.00B) — a net profit margin of -56.24%.
Frequently asked questions
ACUR · 4 questionsAcura Pharmaceuticals, Inc. (ACUR) reported revenue of $0.00B for 2021, down 56.2% year-over-year.
ACUR revenueACUR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09